Celularity Inc. (NASDAQ:CELUW) Sees Significant Drop in Short Interest

Celularity Inc. (NASDAQ:CELUW) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totaling 2,243 shares, a decline of 23.4% from the November 30th total of 2,930 shares. Based on an average daily volume of 9,172 shares, the short-interest ratio is currently 0.2 days. Based on an average daily volume of 9,172 shares, the short-interest ratio is currently 0.2 days.

Celularity Price Performance

Shares of Celularity stock opened at $0.02 on Tuesday. Celularity has a twelve month low of $0.01 and a twelve month high of $0.75. The firm’s 50-day moving average price is $0.02 and its 200 day moving average price is $0.04.

About Celularity

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.